Has the 2004 revision of the International Society of Heart and Lung Transplantation grading system improved the reproducibility of the diagnosis and grading of cardiac transplant rejection?

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA.
Cardiovascular pathology: the official journal of the Society for Cardiovascular Pathology (Impact Factor: 2.34). 08/2008; 18(4):198-204. DOI: 10.1016/j.carpath.2008.05.003
Source: PubMed

ABSTRACT We compared the interobserver reproducibility of the 1990 and 2004 International Society for Heart and Lung Transplantation (ISHLT) grading system for cardiac rejection. The 2004 ISHLT grading system for cardiac allograft rejection did not improve reproducibility partly due to pathologists' disagreement in diagnosing Grades 1B/1R and 3A/2R rejection. To achieve better reproducibility, better criteria for defining 1B/1R vs. 3A/2R rejection and markers of myocyte injury are needed.

  • [Show abstract] [Hide abstract]
    ABSTRACT: We report the performance of the embedded zerotree wavelet (EZW) using successive-approximation quantization and an adaptive arithmetic coding for effective reduction in bit rates while maintaining high visual quality of reconstructed color images. For 24 bit color images, excellent visual quality is maintained upto a bit rate reduction to approximately 0.48 bpp by EZW yielding a compression ratio (CR) of 50:1. Further bit rate reduction to 0.375 bpp results in a visible degradation by EZW, as is the case when using the adaptive vector quantizer AFLC-VQ. However, the bit rate reduction by AFLC-VQ was computed from the quantizer output and did not include any subsequent entropy coding. Therefore entropy coding of the multi-resolution codebooks generated by adaptive vector quantization of the wavelet coefficients in the AFLC-VQ scheme should reduce the bit rate to at least 0.36 bpp (CR 67:1) at the desired quality currently obtainable at 0.48 bpp by EZW
    Data Compression Conference, 1997. DCC '97. Proceedings; 04/1997
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We sought to use cardiac magnetic resonance (CMR) to establish sensitive and reliable indexes for noninvasive detection of acute cardiac allograft rejection. Appropriate surveillance for acute allograft rejection is vitally important for graft survival. The current gold standard for diagnosing and staging rejection after organ transplantation is endomyocardial biopsy, which is not only invasive but also prone to sampling errors. The motivation of this study is to establish a CMR-based alternative that is noninvasive and sensitive for early detection of allograft rejection before irreversible damage occurs. We employed a noninvasive 2-pronged approach to detect acute cardiac allograft rejection using a rodent working heart and lung transplantation model. We used CMR to detect immune-cell infiltration at sites of rejection by monitoring the accumulation of dextran-coated ultra-small superparamagnetic-iron-oxide-labeled immune cells (in particular macrophages) in vivo. Simultaneously, we used CMR tagging and strain analysis to detect regional myocardial function loss resulting from acute rejection. Immune cells infiltration, mainly macrophages and monocytes, could be identified with CMR by in vivo labeling with ultra-small superparamagnetic-iron-oxide. Our data show that immune-cell infiltration in cardiac allograft rejection was highly heterogeneous. Thus, it is not surprising to find inconsistencies between rejection and endomyocardial biopsy results because of the limited number and small samples available. Tagged CMR and strain analysis showed that, as with immune-cell infiltration, ventricular functional loss was also heterogeneous. Although changes in global systolic function were generally not observed until the later stages of rejection, our data revealed that a functional index derived from local strain analysis correlated well with rejection grades, which may be a more sensitive parameter for detecting early rejection. CMR is noninvasive and provides a 3-dimensional, whole-heart perspective of the rejection status, potentially allowing more reliable detection of acute allograft rejection.
    JACC. Cardiovascular imaging 07/2009; 2(6):731-41. DOI:10.1016/j.jcmg.2009.01.013 · 6.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diagnosis of cardiac allograft rejection is currently based on histologic exploration of endomyocardial biopsies. Moderate interobserver reproducibility in the estimation of number and distribution of inflammatory cells leads to disagreements in the assignment of rejection grades. Short-tandem repeat (STR) analysis is routinely used after hematopoietic stem-cell transplantation to determine the proportions of donor cells. We compared the amount of recipient-derived cells with the histopathologic grade of rejection in cardiac allografts to determine whether this method might be useful for the assessment of rejection episodes. One hundred forty-three endomyocardial biopsies from 18 patients were investigated for the percentage of recipient-derived cell content by polymerase chain reaction-based STR analysis and correlated with rejection grades determined according to the International Society for Heart and Lung Transplantation grading system. Y-chromosome chromogene in situ hybridization was performed in gender-mismatched (female-to-male) heart transplants to explore the influence of cardiomyocyte cell chimerism. The mean percentages of recipient-derived cells associated with various degrees of rejection were 13% in grade 0, 24% in grade 1A, 29% in grade 1B, 35% in grade 2, and 50% in grade > or =3A. Samples lacking signs of rejection (grade 0) had a significantly lower (P<0.001) amount of recipient-derived cells than higher degrees of rejections. Chromogene in situ hybridization analysis revealed that the recipient-derived cells were mainly inflammatory. The results of STR-analysis indicate that rejection is correlated with a higher proportion of recipient-derived cells. This assessment is observer independent and may thus represent an additional diagnostic tool for the assessment of rejection and management of immunosuppressive treatment.
    Transplantation 12/2009; 89(6):749-55. DOI:10.1097/TP.0b013e3181cab05c · 3.78 Impact Factor